stoxil
Pharmaranks rates Stoxil 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Stoxil (Idoxuridine) is a medication used to treat Dendritic Keratitis.
Idoxuridine · by Glaxosmithkline
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Idoxuridine
- Form
- Topical, Drops
- Strength
- Idoxuridine 0.1%
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- dendritic keratitis
- Manufacturer
- Glaxosmithkline
- FDA application
- NDA013934
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
- dendritic keratitis
Dosage forms
Topical and Drops
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Stoxil treat?
- Stoxil (Idoxuridine) may be used to treat dendritic keratitis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Stoxil rated?
- pharmaranks gives Stoxil a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Stoxil?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Stoxil. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Stoxil?
- Stoxil is marketed by Glaxosmithkline. You can see Glaxosmithkline's full profile, rating, and other products on pharmaranks.
- Is Stoxil a brand-name or generic drug?
- Stoxil is a brand-name product with the active ingredient Idoxuridine.
- Is Stoxil available over the counter?
- No. Stoxil is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Stoxil come in?
- Stoxil is currently marketed as topical and drops, per the FDA's National Drug Code Directory.
- Is Stoxil FDA-registered?
- Stoxil is on record with the U.S. FDA under application number NDA013934. You can verify this on its official FDA label.
- Has Stoxil been recalled by the FDA?
- Stoxil has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Stoxil safe?
- There's no single safe-or-not verdict. pharmaranks gives Stoxil a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about IDOXURIDINE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 10 reports naming IDOXURIDINE — the active ingredient in Stoxil, and the FDA flagged 70% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- alanine aminotransferase increased3 reports
- aspartate aminotransferase increased3 reports
- blood alkaline phosphatase increased3 reports
- gamma-glutamyltransferase increased3 reports
- hyperaesthesia3 reports
- neuralgia3 reports
- abdominal pain upper2 reports
- hepatocellular damage2 reports
Read these as a signal, not a rate. A report does not mean IDOXURIDINE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
benzamycin
Benzoyl Peroxide and Erythromycin
colazal
Balsalazide Disodium
cuprimine
Penicillamine
mysoline
Primidone
retin-a
Tretinoin
tolak
Fluorouracil
Compare Stoxil head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
stoxil
72/100